University of Texas at San Antonio-ko ikertzaileekin lankidetzan egindako argitalpenak (13)

2016

  1. Examination of the pathogenic potential of Candida albicans filamentous cells in an animal model of haematogenously disseminated candidiasis

    FEMS Yeast Research, Vol. 16, Núm. 2

2012

  1. BRG1 and NRG1 form a novel feedback circuit regulating Candida albicans hypha formation and virulence

    Molecular Microbiology, Vol. 85, Núm. 3, pp. 557-573

  2. Physiologic expression of the Candida albicans pescadillo homolog is required for virulence in a murine model of hematogenously disseminated candidiasis

    Eukaryotic Cell, Vol. 11, Núm. 12, pp. 1552-1556

2011

  1. Candida albicans adhesin Als3p is dispensable for virulence in the mouse model of disseminated candidiasis

    Microbiology, Vol. 157, Núm. 6, pp. 1806-1815

  2. Validation of the Tetracycline regulatable gene expression system for the study of the pathogenesis of infectious disease

    PLoS ONE, Vol. 6, Núm. 5

2010

  1. Pseudohyphal regulation by the transcription factor Rfg1p in Candida albicans

    Eukaryotic Cell, Vol. 9, Núm. 9, pp. 1363-1373

2009

  1. Candida albicans VPS4 is required for secretion of aspartyl proteases and in vivo virulence

    Mycopathologia, Vol. 167, Núm. 2, pp. 55-63

  2. Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis

    Clinical and Vaccine Immunology, Vol. 16, Núm. 3, pp. 430-432

  3. Expression levels of a filament-specific transcriptional regulator are sufficient to determine Candida albicans morphology and virulence

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, Núm. 2, pp. 599-604

2008

  1. UME6, a novel filament-specific regulator of Candida albicans hyphal extension and virulence

    Molecular Biology of the Cell, Vol. 19, Núm. 4, pp. 1354-1365

  2. Use of a genetically engineered strain to evaluate the pathogenic potential of yeast cell and filamentous forms during Candida albicans systemic infection in immunodeficient mice

    Infection and Immunity, Vol. 76, Núm. 1, pp. 97-102

2006

  1. A proteomic-based approach for the identification of Candida albicans protein components present in a subunit vaccine that protects against disseminated candidiasis

    Proteomics, Vol. 6, Núm. 22, pp. 6033-6041

  2. Inhibition of filamentation can be used to treat disseminated candidiasis

    Antimicrobial Agents and Chemotherapy, Vol. 50, Núm. 10, pp. 3312-3316